Madrigal Pharmaceuticals
MDGL
MDGL
135 hedge funds and large institutions have $769M invested in Madrigal Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-3
Holders Change %
-2.17%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
18
Increased
54
Reduced
32
Closed
20
Calls
$19.2M
Puts
$31.4M
Net Calls
-$12.2M
Net Calls Change
-$21.5M
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$11.2M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$62.8M |
| 3 |
AC
3
Armistice Capital
New York
|
$80.3M |
| 4 |
4
Goldman Sachs
New York
|
$11.7M |
| 5 |
GPP
5
Great Point Partners
Greenwich,
Connecticut
|
$6.21M |
